WallStreetZenWallStreetZen

NASDAQ: BIIB
Biogen Inc Stock Ownership - Who owns Biogen?

Insider buying vs selling

Have Biogen Inc insiders been buying or selling?
Buy
Sell
NameRoleDateSharesPriceValue
Adam KeeneyHead of Corporate Development2024-05-01276$216.13
$59.65kSell
Priya SinghalHead of Development2024-04-0293$213.09
$19.82kSell
Nicole MurphyHead of Pharm Ops and Tech2024-04-01117$214.83
$25.14kSell
Priya SinghalHead of Development2024-02-22262$221.23
$57.96kSell
Ginger GregoryEVP Human Resources2024-02-16729$219.08
$159.71kSell
Ginger GregoryEVP Human Resources2024-02-161,535$219.08
$336.29kSell
Priya SinghalHead of Development2024-02-16173$219.08
$37.90kSell
Priya SinghalHead of Development2024-02-16108$221.49
$23.92kSell
Rachid IzzarHead of Global Product Strat.2024-02-16313$219.08
$68.57kSell
Rachid IzzarHead of Global Product Strat.2024-02-16639$219.08
$139.99kSell

1 of 5

BIIB insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when BIIB insiders and whales buy or sell their stock.

BIIB Shareholders

What type of owners hold Biogen Inc stock?
Institutional
Insider
Retail
NameHoldSharesValueType
Vanguard Group Inc11.38%16,570,398$3.82BInstitution
Primecap Management Co11.14%16,220,716$3.74BInstitution
Blackrock Inc9.72%14,144,988$3.26BInstitution
State Street Corp4.63%6,747,008$1.56BInstitution
T Rowe Price Investment Management Inc3.55%5,169,970$1.19BInstitution
Wellington Management Group LLP3.52%5,120,142$1.18BInstitution
Jpmorgan Chase Co3.22%4,694,694$1.08BInstitution
Geode Capital Management LLC2.34%3,409,674$786.17MInstitution
Van Eck Associates Corp1.19%1,737,340$400.58MInstitution
Morgan Stanley1.17%1,701,383$392.29MInstitution

1 of 3

BIIB vs General Drug Manufacturer Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BIIB87.16%2.11%Net SellingNet Selling
OGN76.68%0.20%Net SellingNet Selling
GRFS19.42%0.00%
AMRN21.49%15.40%Net Selling
SCLX15.54%34.70%Net BuyingNet Buying

Biogen Stock Ownership FAQ

Who owns Biogen?

Biogen (NASDAQ: BIIB) is owned by 87.16% institutional shareholders, 2.11% Biogen insiders, and 10.73% retail investors. Vanguard Group Inc is the largest individual Biogen shareholder, owning 16.57M shares representing 11.38% of the company. Vanguard Group Inc's Biogen shares are currently valued at $3.84B.

If you're new to stock investing, here's how to buy Biogen stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.